Positive and negative predictors of LDL-C goals achievement in patients at moderate to very high cardiovascular risk on lipid-lowering drug therapy (CEPHEUS II)
Decades of obesity even without comorbidities in asymptomatic subjects is associated with significant cardiovascular structural and functional abnormalities